+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vitro Lung Model Market by Model Type (2D Cell Cultures, 3D Organoids, Lung-On-A-Chip), Application (Disease Modeling, Drug Discovery & Development, Personalized Medicine), Cell Source, Technology, Product Type, End Users - Global Forecast 2025-2030- Product Image
In Vitro Lung Model Market by Model Type (2D Cell Cultures, 3D Organoids, Lung-On-A-Chip), Application (Disease Modeling, Drug Discovery & Development, Personalized Medicine), Cell Source, Technology, Product Type, End Users - Global Forecast 2025-2030- Product Image
Sale

In Vitro Lung Model Market by Model Type (2D Cell Cultures, 3D Organoids, Lung-On-A-Chip), Application (Disease Modeling, Drug Discovery & Development, Personalized Medicine), Cell Source, Technology, Product Type, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889471
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The In Vitro Lung Model Market is experiencing rapid momentum as advanced cellular platforms reshape the future of respiratory research and therapeutic development. This shift reflects increasing demand for biologically relevant lung models that can improve translational accuracy and accelerate innovation across the healthcare sector.

Market Snapshot: Growth and Emerging Dynamics in the In Vitro Lung Model Market

The global In Vitro Lung Model Market grew from USD 689.38 million in 2024 to USD 812.58 million in 2025. It is projected to maintain significant momentum, achieving a CAGR of 17.05% and reaching USD 1.77 billion by 2030. This robust trajectory is attributed to the escalating demand for predictive preclinical models, advanced drug screening platforms, and rapid adoption of microphysiological systems among research institutions and industry leaders.

Scope & Segmentation: Comprehensive Structure of the In Vitro Lung Model Market

  • Model Types: 2D cell cultures (including cell line and primary cultures), 3D organoids (alveolar and bronchial), lung-on-a-chip devices, precision-cut lung slices
  • Applications: Disease modeling, drug discovery and development, personalized medicine solutions, toxicity and safety testing
  • Cell Sources: Animal-derived cells, human-derived primary and stem cell-based cultures, established and immortalized cell lines
  • Technologies: Microfluidics (continuous flow, droplet-based systems), scaffold-based and scaffold-free cultures (including bioreactors, natural and synthetic matrices)
  • Product Types: Instruments and integrated devices, kits and reagents facilitating advanced lung model workflows
  • End Users: Academic and research institutes, contract research organizations (CROs), pharmaceutical and biotechnology companies, regulatory agencies
  • Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, United Arab Emirates, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and additional markets)
  • Leading Companies: Emulate, Inc.; MIMETAS B.V.; CN Bio Innovations Ltd.; Hurel Corporation; TissUse GmbH; Epithelix Sàrl; MatTek Life Sciences, Inc.; InSphero AG; Kirkstall Ltd; Stemina Biomarker Discovery, Inc.

Key Takeaways for Senior Decision-Makers

  • In vitro lung platforms now replicate intricate lung physiology, closing the gap between traditional models and human clinical environments for improved translational value.
  • Microfluidics, organoid cultures, and lung-on-a-chip devices are gaining traction, offering dynamic modeling of disease, drug response, and toxicology with greater predictive power.
  • Collaborative consortia and public-private partnerships are facilitating standardization, protocol harmonization, and resource sharing to increase operational efficiency and accelerate regulatory approval.
  • Regional innovation is shaping market dynamics—Americas lead with strong investments and established regulation, while Europe, Middle East & Africa focus on ethical and validation frameworks and Asia-Pacific emphasizes manufacturing scalability and cost optimization.
  • Companies are differentiating by integrating automated high-throughput systems, enabling rapid screening and analysis that support both pharmaceutical R&D and regulatory compliance objectives.

Tariff Impact: Implications of 2025 United States Trade Adjustments

Adjustments to United States tariff policies in 2025 have influenced procurement of in vitro lung research materials, causing fluctuations in import duties for critical laboratory components. This has driven research organizations to consider local suppliers and invest in regional manufacturing capabilities, thereby strengthening domestic supply chains. Collaborative procurement and streamlined regulatory pathways for home-produced reagents have helped offset challenges, promoting long-term resiliency in the market ecosystem.

Methodology & Data Sources

The insights presented derive from a systematic review of peer-reviewed papers, patent filings, government and industry reports, and expert consultations with leaders in respiratory biology and bioengineering. Additional input was gathered through structured interviews with senior stakeholders and validated against laboratory protocols and supplier specifications, ensuring robust and actionable intelligence.

Why This Report Matters: Actionable Value for Market Leaders

  • Gain immediate clarity on evolving global and regional trends shaping the adoption and competitive landscape of in vitro lung research solutions.
  • Access a comprehensive segmentation and profiling of supply-side contributors, innovative technologies, and relevant applications critical for informed strategic planning and investment decisions.

Conclusion

The In Vitro Lung Model Market is positioned as a cornerstone for next-generation respiratory research, supporting stakeholder initiatives in R&D, regulatory compliance, and therapy development. Engaging with collaborative and technological advancements will ensure continued progress and competitive advantage in this sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in organ-on-chip microfluidic lung models with integrated mechanical stimulation
5.2. Integration of patient-derived lung organoids for personalized respiratory disease modeling
5.3. Use of 3D bioprinting techniques to create vascularized lung tissue constructs with high fidelity
5.4. Application of AI-driven imaging and high-content screening in in vitro lung toxicity assays
5.5. Development of dynamic lung-on-chip systems simulating mechanical stretch and airflow patterns
5.6. Growing demand for co-culture lung models incorporating epithelial, endothelial, and immune cells for COVID-19 research
5.7. Emerging aerosolized drug delivery testing platforms using advanced in vitro lung exposures
5.8. Standardization and regulatory pathways evolving for acceptance of in vitro lung model data in toxicity testing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. In Vitro Lung Model Market, by Model Type
8.1. Introduction
8.2. 2D Cell Cultures
8.2.1. Cell Line Cultures
8.2.2. Primary Cell Cultures
8.3. 3D Organoids
8.3.1. Alveolar Organoids
8.3.2. Bronchial Organoids
8.4. Lung-On-A-Chip
8.5. Precision-Cut Lung Slices
9. In Vitro Lung Model Market, by Application
9.1. Introduction
9.2. Disease Modeling
9.3. Drug Discovery & Development
9.4. Personalized Medicine
9.5. Toxicity Testing
10. In Vitro Lung Model Market, by Cell Source
10.1. Introduction
10.2. Animal-Derived Cells
10.3. Cell Lines
10.4. Human-Derived Cells
10.4.1. Primary Cells
10.4.2. Stem Cell-Derived Cells
11. In Vitro Lung Model Market, by Technology
11.1. Introduction
11.2. Microfluidics
11.2.1. Continuous Flow Systems
11.2.2. Droplet-Based Systems
11.3. Scaffold-Based Cultures
11.3.1. Natural Scaffolds
11.3.2. Synthetic Scaffolds
11.4. Scaffold-Free Cultures
11.4.1. Bioreactors
11.4.2. Hanging Drop
12. In Vitro Lung Model Market, by Product Type
12.1. Introduction
12.2. Instruments
12.3. Kits & Reagents
13. In Vitro Lung Model Market, by End Users
13.1. Introduction
13.2. Academic & Research Institutes
13.3. CROs
13.4. Pharmaceutical & Biotechnology Companies
13.5. Regulatory Agencies
14. Americas In Vitro Lung Model Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa In Vitro Lung Model Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific In Vitro Lung Model Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Emulate, Inc.
17.3.2. MIMETAS B.V.
17.3.3. CN Bio Innovations Ltd.
17.3.4. Hurel Corporation
17.3.5. TissUse GmbH
17.3.6. Epithelix Sàrl
17.3.7. MatTek Life Sciences, Inc.
17.3.8. InSphero AG
17.3.9. Kirkstall Ltd
17.3.10. Stemina Biomarker Discovery, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. IN VITRO LUNG MODEL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. IN VITRO LUNG MODEL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. IN VITRO LUNG MODEL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. IN VITRO LUNG MODEL MARKET: RESEARCHAI
FIGURE 28. IN VITRO LUNG MODEL MARKET: RESEARCHSTATISTICS
FIGURE 29. IN VITRO LUNG MODEL MARKET: RESEARCHCONTACTS
FIGURE 30. IN VITRO LUNG MODEL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IN VITRO LUNG MODEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINE CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINE CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELL CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELL CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ALVEOLAR ORGANOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ALVEOLAR ORGANOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BRONCHIAL ORGANOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BRONCHIAL ORGANOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY LUNG-ON-A-CHIP, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY LUNG-ON-A-CHIP, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRECISION-CUT LUNG SLICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRECISION-CUT LUNG SLICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DISEASE MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ANIMAL-DERIVED CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ANIMAL-DERIVED CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CELL LINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRIMARY CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY STEM CELL-DERIVED CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CONTINUOUS FLOW SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DROPLET-BASED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY DROPLET-BASED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY NATURAL SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY NATURAL SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SYNTHETIC SCAFFOLDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HANGING DROP, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY HANGING DROP, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL IN VITRO LUNG MODEL MARKET SIZE, BY REGULATORY AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES IN VITRO LUNG MODEL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 150. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 151. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 152. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 153. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 154. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 155. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 158. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 159. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 160. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 161. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 162. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 163. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 164. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 165. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 166. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 167. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 168. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 169. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 172. CANADA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 190. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 191. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 192. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 193. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA IN VITRO LUNG MODEL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 296. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 297. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 298. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 299. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 300. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 301. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 304. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 305. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 306. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2025-2030 (USD MILLION)
TABLE 307. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 308. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 309. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 310. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 311. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2018-2024 (USD MILLION)
TABLE 312. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-BASED CULTURES, 2025-2030 (USD MILLION)
TABLE 313. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2018-2024 (USD MILLION)
TABLE 314. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY SCAFFOLD-FREE CULTURES, 2025-2030 (USD MILLION)
TABLE 315. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 316. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 317. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
TABLE 318. GERMANY IN VITRO LUNG MODEL MARKET SIZE, BY END USERS, 2025-2030 (USD MILLION)
TABLE 319. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2018-2024 (USD MILLION)
TABLE 320. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY MODEL TYPE, 2025-2030 (USD MILLION)
TABLE 321. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2018-2024 (USD MILLION)
TABLE 322. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY 2D CELL CULTURES, 2025-2030 (USD MILLION)
TABLE 323. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2018-2024 (USD MILLION)
TABLE 324. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY 3D ORGANOIDS, 2025-2030 (USD MILLION)
TABLE 325. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 328. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 329. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIVED CELLS, 2018-2024 (USD MILLION)
TABLE 330. FRANCE IN VITRO LUNG MODEL MARKET SIZE, BY HUMAN-DERIV

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this In Vitro Lung Model market report include:
  • Emulate, Inc.
  • MIMETAS B.V.
  • CN Bio Innovations Ltd.
  • Hurel Corporation
  • TissUse GmbH
  • Epithelix Sàrl
  • MatTek Life Sciences, Inc.
  • InSphero AG
  • Kirkstall Ltd
  • Stemina Biomarker Discovery, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 812.58 Million
Forecasted Market Value ( USD ) by 2030 $ 1770 Million
Compound Annual Growth Rate17.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

In Vitro Lung Model - Global Strategic Business Report - Product Image

In Vitro Lung Model - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
In Vitro Lung Model Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

In Vitro Lung Model Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
In Vitro Lung Models Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography - Product Image

In Vitro Lung Models Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

  • Report
  • 231 Pages
  • Global
From
In-Vitro Lung Model Market Report 2025 - Product Image

In-Vitro Lung Model Market Report 2025

  • Report
  • 200 Pages
  • Global
From
In Vitro Lung Model Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

In Vitro Lung Model Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 87 Pages
  • Global
From

About the In Vitro Lung Model Market

The In Vitro Lung Model market is a subset of the In Vitro Diagnostics (IVD) industry. It is composed of products and services used to simulate the human lung in a laboratory setting. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. In Vitro Lung Models are typically composed of a combination of cell cultures, organoids, and 3D printed scaffolds. These models are used to study the effects of drugs, toxins, and other substances on the respiratory system. They are also used to develop new treatments and therapies for respiratory diseases. The In Vitro Lung Model market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Thermo Fisher Scientific, Merck KGaA, PromoCell, Lonza, and Corning. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.